Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 3042 - Provider product page
- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#3042, RRID:AB_10694238
- Product name
- MAPKAPK-2 Antibody
- Antibody type
- Polyclonal
- Reactivity
- Human, Mouse, Rat, Simian
- Host
- Rabbit
- Storage
- -20°C
Submitted references Casein kinase 2 regulates the mRNA-destabilizing activity of tristetraprolin.
RNA-binding protein AUF1 regulates lipopolysaccharide-induced IL10 expression by activating IkappaB kinase complex in monocytes.
MK2 SUMOylation regulates actin filament remodeling and subsequent migration in endothelial cells by inhibiting MK2 kinase and HSP27 phosphorylation.
MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation.
Lee WH, Lee HH, Vo MT, Kim HJ, Ko MS, Im YC, Min YJ, Lee BJ, Cho WJ, Park JW
The Journal of biological chemistry 2011 Jun 17;286(24):21577-87
The Journal of biological chemistry 2011 Jun 17;286(24):21577-87
RNA-binding protein AUF1 regulates lipopolysaccharide-induced IL10 expression by activating IkappaB kinase complex in monocytes.
Sarkar S, Han J, Sinsimer KS, Liao B, Foster RL, Brewer G, Pestka S
Molecular and cellular biology 2011 Feb;31(4):602-15
Molecular and cellular biology 2011 Feb;31(4):602-15
MK2 SUMOylation regulates actin filament remodeling and subsequent migration in endothelial cells by inhibiting MK2 kinase and HSP27 phosphorylation.
Chang E, Heo KS, Woo CH, Lee H, Le NT, Thomas TN, Fujiwara K, Abe J
Blood 2011 Feb 24;117(8):2527-37
Blood 2011 Feb 24;117(8):2527-37
MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation.
Manke IA, Nguyen A, Lim D, Stewart MQ, Elia AE, Yaffe MB
Molecular cell 2005 Jan 7;17(1):37-48
Molecular cell 2005 Jan 7;17(1):37-48
No comments: Submit comment
No validations: Submit validation data